Webinar: Smooth Switch to the EAEU Marketing Authorization for Medicinal Products
The webinar will highlight the practical tips and guide you through the crucial steps of marketing authorization upgrade to the Eurasian Economic Union (EAEU) one, ultimately leading you towards a successful submission strategy development.
As of now, all national medicinal product marketing authorizations are valid in EAEU until their expiry date. However, the mentioned marketing authorizations must be revalidated according to the EAEU regulations until December 31st, 2025.
You will learn:
What do you need to prepare and implement now to timely and successfully transition to the EAEU marketing authorization?
- What are the main points you need to consider when going into the upgrade procedure?
- What do you need to know about EAEU GMP certification?
- What are the readability user testing requirements?
- Timelines
Preparing for a marketing authorization upgrade?
Create a successful submission strategy development. Explore your options in an informal chat.
Who Should Attend?
Professionals from the following fields:
- Regulatory Managers
- Regulatory Strategy Managers
- RA Partnerships Operations Manager
- QA Managers supporting RA
- RA Healthcare Compliance Managers
Duration: 45 min.
Speaker: Regulatory Affairs Project Manager CIS, Nargiz Asgarova, who will share her expertise regarding drug registration in the Eurasian Economic Union.
Nargiz Asgarova
Regulatory Affairs Project Manager CIS
Other content that might interest you:
Local Affiliate Services That Deliver the Best Results
Find out how local affiliate services can reduce compliance risks and support effective regulatory strategies in the pharma industry.
Harmonizing Product Information Across Baltic Markets
Navigating multilingual product information across several markets can be complex – but it doesn’t have to be. In this case study, we share how one of our partner companies successfully harmonized their SmPC, PIL, and labelling across the Baltic region, working with...
Dossier Transformation for Market Expansion
Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe. In this case study, we break down...
